Basic Information
| LncRNA/CircRNA Name | LINC00355 |
| Synonyms | NA |
| Region | GRCh38_13:63986371-64076011 |
| Ensemble | ENSG00000227674 |
| Refseq | NR_145420 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | 2 | ||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR, Western blot etc. |
| Sample | transitional cell carcinoma of bladder samples |
| Expression Pattern | up-regulated |
| Function Description | LINC00355, UCA1-203, and MALAT1 expression was significantly higher in TCC patients compared to controls (non-malignant or normal samples). |
| Pubmed ID | 30568497 |
| Year | 2018 |
| Title | Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer |
External Links
| Links for LINC00355 | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |